Company Description
Almirall SA (OTC Link: ALMRY) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $2.8B.
ALMRY has gained 47.6% over the past year. Shares last traded at $14.29.
This page collects what Stock Titan holds for ALMRY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Almirall SA (ALMRY) stock last closed at $14.29. Over the past 12 months, the stock has gained 47.6%. At a market capitalization of $2.8B, ALMRY is classified as a mid-cap stock with approximately 214.6M shares outstanding.
Latest News
Almirall SA has 7 recent news articles. Key topics include conferences, clinical trial. View all ALMRY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Almirall SA (ALMRY) currently stands at 100 shares, a new position with no short interest reported in the previous period.
Days to Cover History
Days to cover for Almirall SA (ALMRY) currently stands at 4.3 days, up 335% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 335% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 4.3 days.
ALMRY Company Profile & Sector Positioning
Almirall SA (ALMRY) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ALMRY often look at related companies in the same sector, including Procaps Group Sa (PROCF), Almirall (LBTSF), Hypera Sa (HYPMY), Hikma Pharmaceuticals Plc (HKMPY), and Hikma Pharma (HKMPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ALMRY's relative position within its industry.